Page 273 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 273

252   PART III    Therapeutic Modalities for the Cancer Patient



          TABLE 15.1     Gene Therapy Vector Systems
            Viral Vectors
  VetBooks.ir  Retroviruses    Originally the gold-standard vector. Gene is packaged into replication-defective viral particles using a packaging cell line. The
              (oncoviruses)
                              therapeutic gene is integrated into the host cell genome when the virus is delivered to the target cell. Limited by their inability to
                              infect postmitotic cells.
            Retroviruses     Many are based on HIV-1. These vectors have become safer in recent years and have many of the benefits of the oncoviruses
              (lentivirus)    and also will infect postmitotic cells. Construction of the vector takes place in a packaging cell line and the therapeutic gene is
                              integrated into the host cell genome.
            Adenoviruses     Have become the most popular viral delivery mechanism. Gene is packaged into a replication incompetent adenovirus (usually
                              E1 deleted). Gene expression remains episomal when delivered to the host cell. Concerns have been raised about the safety
                              of adenoviral vectors, in particular potential toxic side effects at high doses. Adenoviruses can infect a wide range of pre- and
                              postmitotic cells. Conditionally replicating adenoviruses are being explored as oncolytic vectors.
            Adeno-associated   Gaining popularity as a vector as they are potentially safer than adenoviruses. They infect a wide variety of mammalian cell types
              viruses (AAV)   but are limited by the amount of DNA they can deliver. Gene expression in the host cell is episomal. However, in the natural host,
                              integration is possible.
            Nonviral Vectors
            Naked DNA        This is a simple form of gene delivery in which “naked” plasmid DNA is directly injected into the tumor. Vectors are derived from
                              bacterial plasmids and are engineered to express the therapeutic gene under the control of a strong promoter. Naked DNA can be
                              taken up by many tissues, but typically the efficiency for delivery is lower than that for viral gene delivery.
            Particle bombardment   This is a more sophisticated approach to the delivery of naked DNA. In this system plasmid DNA is typically adsorbed onto gold
              (gene gun)      particles. Helium is then used as a motive force to fire the gold particles into cells or tissues via a hand-held “gene gun.”
            Liposome/DNA     In this system naked DNA is coated with liposomes to improve uptake by endocytosis. This enhances the efficiency of gene delivery.
                conjugates
            Ligand/DNA       Ligands are used to specifically target DNA to tumor tissue.
                conjugates
            HIV-1, Human immunodeficiency virus-1.










                                                         Retrovirus
                                                                         Adeno-Associated Virus
                                     Adenovirus
                                                      Promoter  Transcription initiation
                                                              Gene
                             Viral Delivery
                              Nonviral Delivery





                                                                                 DNA
                                                                                 adsorbed on  Target Cell
                                                                                 to gold
                                                                                 particles
                                         Plasmid DNA                   Biolistic Gene Gun
                          • Fig. 15.1  Viral and nonviral gene delivery. Adenoviral vectors are produced in “producer cell lines.” They
                          enter the cell by transduction and their genetic material is transported to the nucleus. In contrast to retro-
                          viruses, the DNA is not integrated into the host genome, but gene expression is achieved episomally. Ret-
                          roviral vectors are also produced is specialized producer cell lines. They enter the cell by transduction but
                          their RNA genome is reverse transcribed into proviral DNA. This integrates into the host genome, where
                          expression of the transgene takes place. DNA plasmid vectors contain a gene cassette that incorporates
                          the therapeutic transgene under the control of a promoter. The plasmid can be delivered by direct injection
                          as naked or liposome encapsulated DNA, by direct injection or systemically wrapped in nanomedicine
                          particles, or by direct injection utilizing a helium-driven “biolistic” gene gun.
   268   269   270   271   272   273   274   275   276   277   278